Protracted COVID-19 pneumonia in B-cell-depleted patients
- PMID: 39714289
- PMCID: PMC11962908
- DOI: 10.1093/rheumatology/keae703
Protracted COVID-19 pneumonia in B-cell-depleted patients
References
-
- Zonozi R, Cortazar FB, Jeyabalan A. et al. Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial. Ann Rheum Dis 2024;83:351–9. - PubMed
-
- Zonozi R, Walters LC, Shulkin A. et al. T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19. Sci Transl Med 2023;15:eadh4529. - PubMed
-
- COVID-19 treatment guidelines. Clinical spectrum. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/ (23 July 2024, date last accessed).
LinkOut - more resources
Full Text Sources
